Medius recognized in the 2021 Gartner® Critical Capabilities for Procure-to-Pay Suites report

We feel our recognition in the Gartner® report [1] is a testament to our extensive background in AP Automation and our comprehensive spend management suite and recognition in the report shows that our customer-centric strategy to build solutions from the ground up with modern technology is working.

This news comes just months after Medius was named a Visionary in the October 2021 Gartner® Magic Quadrant™ for Procure-to-Pay (P2P) Suites report [2].

Complete the form to access your copy of the 2021 Gartner® Critical Capabilities for Procure-to-Pay Suites.

 

What you’ll find in the full report:

  • What you need to know to identify the right P2P solution
  • The Critical Capabilities methodology
  • Complete details of all positioned players in the Critical Capabilities for 2021, including individual strengths and cautions of their offerings
 
Download the complete report today using the form below.

Would you like to receive content for finance and procurement professionals via email?

In order to fulfill your request, we will process your personal data as outlined in our Privacy Policy

Gartner Disclaimer:

[1] Gartner, Critical Capabilities for Procure-to-Pay Suites, By Micky KeckWilliam McNeillKaitlynn SommersPatrick Connaughton, 15 November 2021.

[2] Gartner, Magic Quadrant for Procure-to-Pay Suites, 25 October 2021, Kaitlynn Sommers et. Al.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.